PTEN and neoplasm: While PRINCe is necessarily limited to megabase resolution for copy number alteration detection at ultra-low-pass (~0.01x) whole-genome coverage, smaller (multi-kilobase) clinically relevant focal alterations (including focal PTEN deletion) can clearly be detected at 0.01–0.1x genome-wide coverages with sufficient cfDNA tumor content (Figure 5B).